State-of-the-art update and review: clinical trials of lipid-lowering agents

This publication has 68 references indexed in Scilit:

• The antiatherogenic role of high-density lipoprotein cholesterol
  The American Journal of Cardiology, 1998
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
  Journal of Clinical Investigation, 1998
• Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men
  The American Journal of Cardiology, 1996
• Epidemiology of triglycerides: A view from Framingham
  The American Journal of Cardiology, 1992
• Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
  The American Journal of Cardiology, 1992
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study
  American Heart Journal, 1987
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality
  Journal of Chronic Diseases, 1978